NTU Singapore is introducing two new undergraduate degree programmes in robotics and advanced chemical and pharmaceutical manufacturing in August ...

AstraZeneca is building a US$1.5 billion manufacturing facility in Tuas South, Singapore, which will create over 800 jobs.

Applied Materials South East Asia Pte. Ltd. and the National University of Singapore (NUS) are furthering their collaboration to bring advanced semiconductor research capabilities and talent ...

Ring Therapeutics is calling on Singaporean research agencies to dial into a new collaboration to develop gene therapies for eye diseases and cancer. | Ring Therapeutics is calling on Singaporean ...

The new facility in Singapore will be the latest in HCLTech’s network of global AI labs set up to help businesses deploy artificial intelligence applications and build local talent.

GSK is on track to achieve its guidance for 2024, with its Q3 2024 and 9m 2024 results today. Explore more details here.

GSK Plc acquired an experimental drug from Chinese biotech firm Chimagen Biosciences for as much as $850 million, adding to ...

The expansion will create over 200 new jobs and supply sterile liquid vaccines and medicines for which GSK said there is an “ever-increasing demand”. As for the site’s carbon footprint, buildings will ...

But if you’re in the mood to try something new this year, we got you. This guide is packed with all the Deepavali 2024 Singapore events and activities you’ll want to explore. This year, Deepavali ...

It is the second RSV vaccine made available in Singapore for the age group. GSK vaccine Arexvy was the first to be approved by the Singapore authorities in May 2024. The Health Ministry said the ...

SINGAPORE – The authorities on Oct 22 ordered the blocking of 10 fake websites linked to foreign actors that could potentially be used to carry out disinformation campaigns against Singapore.

GSK has announced a £50m ($54.3m) investment in a new partnership with the University of Cambridge and Cambridge University Hospitals to expedite immune-related disease research and development (R&D).